11
Participants
Start Date
April 29, 2021
Primary Completion Date
June 5, 2023
Study Completion Date
June 5, 2023
AMG 994
Administered as an intravenous (IV) infusion.
AMG 404
Administered as an intravenous (IV) infusion.
Monash Medical Centre, Clayton
Linear Clinical Research Limited, Nedlands
Universitair Ziekenhuis Gent, Ghent
Sarah Cannon Research Institute, Nashville
University Hospitals Cleveland Medical Center, Cleveland
Henry Ford Hospital, Henry Ford Health Systems, Detroit
Centre Leon Berard, Lyon
University of Texas MD Anderson Cancer Center, Houston
Universitatsklinikum Ulm, Ulm
City of Hope National Medical Center, Duarte
Universitätsklinikum Würzburg, Würzburg
Princess Margaret Cancer Centre, Toronto
National Cancer Center Hospital East, Kashiwa-shi
National Hospital Organization Shikoku Cancer Center, Matsuyama
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw
Hospital Universitari Vall d Hebron, Barcelona
University College London Hospital, London
Lead Sponsor
Amgen
INDUSTRY